We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio A lack of EULAR/European Renal ...
Please provide your email address to receive an email when new articles are posted on . Routine, proactive therapeutic drug monitoring for patients receiving biopharmaceuticals for rheumatic and ...
ROCKVILLE, Md. & EDMONTON, Alberta--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) – Aurinia welcomes the 2023 updated recommendations from The European Alliance ...
EULAR - The European Alliance of Associations for Rheumatology - has developed a new disease activity score that quantifies the level of disease activity in people with antiphospholipid syndrome (APS) ...
To our knowledge no prospective double-blinded, placebo-controlled studies have investigated the utility of miRNAs in whole blood as predictive biomarkers of treatment response in patients with RA. We ...
human kidney cross section Researchers evaluated EULAR/ERA-EDTA response to therapy in patients with lupus nephritis. Lack of renal response to therapy at 12 months predicts chronic kidney disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback